Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Trend
Mixed MA signals — sideways/transition
Price Action
Support & Resistance Levels
Volume Analysis
Recent MA Crossovers
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹57.9 Cr | ₹49.6 Cr | ₹49.8 Cr | ₹55.9 Cr |
| Net Profit | ₹65.4 Cr | ₹68.4 Cr | ₹61.6 Cr | ₹128.5 Cr |
| EPS | ₹2.55 | — | ₹2.40 | ₹5.00 |
| Operating Profit | ₹30.8 Cr | ₹30.3 Cr | ₹23.2 Cr | ₹88.2 Cr |
Peer Comparison
Residential Commercial ProjectsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| DLF Limited | ₹685.75 | +3.96% | 62.3 | ₹1.70L Cr large Cap | |
| Lodha Developers Limited | ₹1,220.75 | +2.40% | 34.8 | ₹1.22L Cr large Cap | |
| The Phoenix Mills Limited | ₹2,138.90 | +2.44% | 48.0 | ₹76.49K Cr mid Cap | |
| Prestige Estates Projects Limited | ₹1,733.20 | +3.54% | 54.5 | ₹74.65K Cr mid Cap | |
| Oberoi Realty Limited | ₹1,924.80 | +2.75% | 27.4 | ₹69.99K Cr mid Cap | |
| Godrej Properties Limited | ₹2,133.00 | +5.08% | 31.6 | ₹64.25K Cr mid Cap | |
| Anant Raj Limited | ₹585.85 | +2.88% | 37.0 | ₹21.08K Cr small Cap | |
| Sobha Limited | ₹1,511.30 | +2.82% | 81.1 | ₹16.16K Cr small Cap | |
| Brigade Enterprises Limited | ₹574.60 | +7.60% | 24.0 | ₹14.05K Cr small Cap | |
| Signatureglobal (India) Limited | ₹848.85 | +4.96% | 10.4 | ₹11.93K Cr small Cap | |
| Alembic Limited | ₹89.97 | +1.36% | 18.1 | ₹2.31K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 05 Aug 2025 | Dividend - Rs 2.40 Per Share | DIVIDEND |
| 05 Aug 2024 | Dividend - Rs 2.4 Per Share | DIVIDEND |
| 03 Aug 2023 | Dividend - Rs 2.20 Per Share | DIVIDEND |
| 12 Sept 2022 | Dividend - Rs 1.80 Per Share | DIVIDEND |
| 29 Jul 2021 | Annual General Meeting/Dividend - Rs 0.20 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ALEMBICLTD
View All
Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel
Alembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval, for the 5% strength, means the company can now market its version, which is therapeutically equivalent to Almirall's Aczone Gel. This development marks a significant step for Alembic in the US market, offering a new option for acne sufferers.
Alembic Pharma rises after receiving USFDA approval for Dapsone Gel, 5%
Alembic Pharmaceuticals rose 1.89% to Rs 786.05 after the company said that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Dapsone Gel, 5%.
Alembic Pharmaceuticals receives USFDA final approval for Dapsone Gel
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dapsone Gel, 5%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Aczone Gel, 5%, of Almirall, LLC.